Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera
Ann Hematol
.
2021 May;100(5):1335-1336.
doi: 10.1007/s00277-021-04431-0.
Epub 2021 Jan 20.
Authors
Ivan Krečak
1
,
Hrvoje Holik
2
,
Božena Coha
2
,
Martina Morić Perić
3
,
Ivan Zekanović
3
,
Marija Valovičić Krečak
4
,
Velka Gverić-Krečak
5
,
Marko Lucijanić
6
7
Affiliations
1
Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia. krecak.ivan@gmail.com.
2
Department of Internal Medicine, "Dr. Josip Benčević" General Hospital, Slavonski Brod, Croatia.
3
Department of Internal Medicine, General Hospital Zadar, Zadar, Croatia.
4
Department of Psychiatry, General Hospital of Šibenik-Knin County, Šibenik, Croatia.
5
Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia.
6
University Hospital Dubrava, Zagreb, Croatia.
7
School of Medicine, University of Zagreb, Zagreb, Croatia.
PMID:
33474630
DOI:
10.1007/s00277-021-04431-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Lipoproteins, LDL
Polycythemia Vera*
Risk Factors
Thrombocythemia, Essential*
Thrombosis*
Substances
Lipoproteins, LDL